<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03877003</url>
  </required_header>
  <id_info>
    <org_study_id>H18-126</org_study_id>
    <nct_id>NCT03877003</nct_id>
  </id_info>
  <brief_title>Plasma TMAO and Choline Levels in Individuals With Metabolic Syndrome - Comparison Between Eggs and Choline Supplement.</brief_title>
  <official_title>Plasma TMAO and Choline Levels in Individuals With Metabolic Syndrome - Comparison Between Eggs and Choline Supplement Intake</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Connecticut</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Egg Board</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Connecticut</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine the effects of consuming either 3 eggs per day
      and compare it to daily choline supplement (choline bitartrate) for a dose of approximately
      400 mg/day on plasma concentrations of high density lipoprotein cholesterol (HDL-c),
      trimethylamine N oxide (TMAO) and plasma choline. The goal is to determine if choline given
      as phosphatidyl choline (from eggs) will have a more beneficial effect on plasma choline and
      microbiota.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Epidemiological data suggests that egg intake does not increase the risk for cardiovascular
      disease (CVD). In fact eggs are a good source of phosphatidyl choline (PC) and choline has a
      number of metabolic roles including lipid metabolism, membrane structure, liver health and a
      neurotransmitter. Recent reports that choline may be metabolized by the intestinal microbiota
      into TMAO, a compound that may increase the risk for heart disease. It is not clear how much
      egg contribute to TMAO formation in individuals with metabolic syndrome.

      Therefore the objective of this study is to determine the impact of daily intake of 3 eggs
      versus a choline supplement on plasma TMAO and other biomarkers for CVD risk and also to
      assess if there are changes in microbiota with these interventions that might lead to the
      increases of TMAO in plasma.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Actual">December 14, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Randomized crossover design</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma choline and TMAO (micromol/L)</measure>
    <time_frame>1 year</time_frame>
    <description>They will be measured simultaneously by use of a mass spectrophotometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma lipids (total cholesterol, HDL cholesterol and triglycerides) in mg/dL</measure>
    <time_frame>1 year</time_frame>
    <description>They will be measured simultaneoulsy by use of an automated spectrophotometer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analysis of microbiota diversity (expressed as concentrations of different microorganisms.</measure>
    <time_frame>1 year</time_frame>
    <description>All microorganisms are assayed simultaneously</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Diabetes</condition>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Egg Intake</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consumption of 3 eggs per day for breakfast during 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Choline Supplement Intake</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consumption of choline supplement 1.5 tablets (approx. 400 mg) with breakfast for 4 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Eggs</intervention_name>
    <description>Eggs: Consume 3 eggs per day for 4 weeks Choline supplement: Consume 1.5 pills per day for 4 weeks</description>
    <arm_group_label>Choline Supplement Intake</arm_group_label>
    <arm_group_label>Egg Intake</arm_group_label>
    <other_name>Dietary supplement (choline bitartrate)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All genders

          -  35-70 years

          -  Metabolic syndrome (based on 3 out of 5 characteristics: waist circumference &gt; 88 cm
             for women and &gt; 102 cm for men, plasma triglycerides &gt; 150 mg/dL, fasting glucose &gt;
             100 mg/dL, blood pressure &gt; 135/85 and HDL &lt; 40 mg/dL for men and &lt; 50 mg/dL for
             women),

          -  willing to consume 3 eggs per day for 4 weeks

          -  willing to consume choline supplement (400 mg/day for 4 weeks)

        Exclusion Criteria:

          -  Self-reported diaberes, cardiovascular disease, history of stroke, liver disease or
             cancer

          -  Taking glucose lowering medications

          -  Taking antibiotics in the previous 1 month

          -  Triglycerides &gt; 500 mg/dL,

          -  Cholesterol &gt; 240 mg/dL,

          -  blood pressure &gt; 145/100 mm of Hg

          -  Allergic to eggs or to choline
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maria-Luz Fernandez, phD</last_name>
    <phone>860-486-5547</phone>
    <email>maria-luz.fernandez@uconn.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Nutritional Sciences</name>
      <address>
        <city>Storrs</city>
        <state>Connecticut</state>
        <zip>06269</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria-Luz Fernandez, PhD</last_name>
      <phone>860-486-5547</phone>
      <email>maria-luz.fernandez@uconn.edu</email>
    </contact>
    <contact_backup>
      <last_name>Minu S Thomas, MS</last_name>
      <email>minu.thomas@uconn.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Connecticut</name>
      <address>
        <city>Storrs</city>
        <state>Connecticut</state>
        <zip>06269</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria-Luz Fernandez, Phd</last_name>
      <phone>860-486-5547</phone>
      <email>maria-luz.fernandez@uconn.edu</email>
    </contact>
    <investigator>
      <last_name>Maria Luz Fernandez, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>March 13, 2019</study_first_submitted>
  <study_first_submitted_qc>March 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2019</study_first_posted>
  <last_update_submitted>January 13, 2020</last_update_submitted>
  <last_update_submitted_qc>January 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Connecticut</investigator_affiliation>
    <investigator_full_name>Maria Luz Fernandez</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>eggs,</keyword>
  <keyword>choline</keyword>
  <keyword>metabolic syndrome</keyword>
  <keyword>TMAO</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Choline</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

